MicroRNA Childhood Cancer Catalog (M3Cs)

Publication Title	DOI	Year
Circulating MicroRNA-21, MicroRNA-23a, and MicroRNA-125b as Biomarkers for Diagnosis and Prognosis of Burkitt Lymphoma in Children	https://doi.org/10.12659/msm.897417	2016	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 2 Master/Detail View
High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma	https://doi.org/10.1002/gcc.10316	2004	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
miR-17-92 cluster components analysis in Burkitt lymphoma: overexpression of miR-17 is associated with poor prognosis	https://doi.org/10.1007/s00277-016-2653-7	2016	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Prognostic relevance of miR-124-3p and its target TP53INP1 in pediatric ependymoma.	https://doi.org/10.1002/gcc.22467	2017	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Upregulation of miR-20a and miR-106b is involved in the acquisition of malignancy of pediatric brainstem gliomas.	https://doi.org/10.3892/or.2012.1927	2012	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 2 Master/Detail View
Comprehensive analysis of a microRNA expression profile in pediatric medulloblastoma.	https://doi.org/10.3892/mmr.2017.6490	2017	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 9 Master/Detail View
Prognostic and microRNA profile analysis for CD44 positive expression pediatric posterior fossa ependymoma.	https://doi.org/10.1007/s12094-018-1876-6	2018	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 15 Master/Detail View
Integrated analysis of miRNA and mRNA expression in childhood medulloblastoma compared with neural stem cells.	https://doi.org/10.1371/journal.pone.0023935	2011	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 33 Master/Detail View
Transcribed-Ultra Conserved Region expression is associated with outcome in high-risk neuroblastoma	https://doi.org/10.1186/1471-2407-9-441	2009	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 13 Master/Detail View
The miR-17-92 microRNA cluster regulates multiple components of the TGF-? pathway in neuroblastoma	https://doi.org/10.1016/j.molcel.2010.11.038	2010	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 6 Master/Detail View
Association of microRNA 21 With Biological Features and Prognosis of Neuroblastoma	https://doi.org/10.1177/107327481602300113	2016	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples	https://doi.org/10.1158/1078-0432.CCR-11-0610	2011	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 25 Master/Detail View
Extension of microRNA expression pattern associated with high-risk neuroblastoma	https://doi.org/10.1007/s13277-013-0777-0	2013	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 39 Master/Detail View
Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms.	https://doi.org/10.1186/s13045-014-0096-y	2014	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-15a and miR-24-1 as putative prognostic microRNA signatures for pediatric pilocytic astrocytomas and ependymomas	https://doi.org/10.1007/s13277-016-4903-7	2016	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 4 Master/Detail View
Molecular analysis of pediatric brain tumors identifies microRNAs in pilocytic astrocytomas that target the MAPK and NF-kappaB pathways.	https://doi.org/10.1186/s40478-015-0266-3	2015	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 8 Master/Detail View
PLK1-associated microRNAs are correlated with pediatric medulloblastoma prognosis	https://doi.org/10.1007/s00381-017-3366-5	2017	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Expression of two parental imprinted miRNAs improves the risk stratification of neuroblastoma patients	https://doi.org/10.1002/cam4.264	2014	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 2 Master/Detail View
Upregulation of mir-221 and mir-222 in atypical teratoid/rhabdoid tumors: potential therapeutic targets.	https://doi.org/10.1007/s00381-009-1028-y	2009	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 2 Master/Detail View
Circulating serum oncologic miRNA in pediatric juvenile pilocytic astrocytoma patients predicts mural nodule volume.	https://doi.org/10.1007/s00701-018-3589-6	2018	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 8 Master/Detail View

Publications